Issue 31 | Week of 2 November 2026 Transcatheter Cardiovascular Therapeutics (TCT) 2026 opened in San Diego on 31 October. This week's issue covers research published between 25 and 31 October, including a randomised trial featured at the meeting. TCT's major randomised results will follow in next
Issue 30 | Week of 26 October 2026 No major cardiology congress fell in this week's evidence window, so the findings below come from journal publication, ahead of Transcatheter Cardiovascular Therapeutics (TCT) 2026, which opens in San Diego on 31 October. Cardiology Intelligence Briefing: the average is not the
Issue 29 | Week of 19 October 2026 Cardiology Intelligence Briefing: what the headline doesn't tell you Every week, cardiology is handed a set of headline numbers. This week's papers are a reminder that the headline is where reading begins, not where it ends. Start with what
Issue 28 | Week of 12 October 2026 The Heart Failure Society of America (HFSA) Annual Scientific Meeting ran in Phoenix from 9 to 12 October. This week's five papers are new journal publications, two of them reporting trials first presented at congresses earlier in the year. Cardiology Intelligence
Issue 27 | Week of 5 October 2026 The European Association for the Study of Diabetes (EASD) Annual Meeting took place in Milan from 28 September to 2 October, and several of the week's cardiometabolic trials were published while it was under way. Cardiology Intelligence Briefing: care is leaving
Issue 26 | Week of 28 September 2026 Cardiology Intelligence Briefing: the marker is not the outcome Cardiology depends on markers. The corrected QT interval (QTc), valve gradients and pressure drops across coronary stenoses give us measurable signals before we know whether a patient will develop an arrhythmia, heart failure, myocardial
Issue 25 | Week of 21 September 2026 Cardiology Intelligence Briefing: knowing where the evidence ends No flagship cardiology congress fell this week, so the evidence came from journals, and most of it was a second look at established treatments: pooled trials, subgroup analyses and secondary analyses. That is no criticism.
Electrophysiology
Issue 24 | Week of 14 September 2026 Cardiology Intelligence Briefing: diagnosis outpaces treatment This was a week in which cardiology got sharper at telling patients apart, while two plausible treatments failed to deliver.34 A large European cohort showed that combining cardiac imaging with genetic testing separates high and low
Structural Heart & TAVI
Issue 23 | Week of 7th September 2026 ESC Congress 2026 concluded in Munich on 31 August. This issue covers papers first published on 30 and 31 August, plus CARDIO-TTRansform, first published on 28 August and held over from last issue by editorial choice. Cardiology Intelligence Briefing: what a result
Lipids & Prevention
Issue 22 | Week of 1 September 2026 ESC Congress 2026 is taking place in Munich this week, running from 28 to 31 August, one of the largest Hot Line weeks in the meeting's recent history. This issue covers papers first published on 28 and 29 August; papers first
Heart Failure
Issue 21 | Week of 24 August 2026 No major cardiology congress fell this week. The European Society of Cardiology (ESC) Congress 2026 begins next week in Munich, running 28 to 31 August. Cardiology Intelligence Briefing: how far the evidence travels Once a therapy, test, or clinical pathway has been shown
Lipids & Prevention
Issue 20 | Week of 17th August 2026 No major cardiology congress fell this week. The strongest evidence came from The Lancet Healthy Longevity, JACC's special issue on obesity, JAMA Cardiology, and the European Heart Journal. Cardiology Intelligence Briefing: the trouble with average Cardiovascular evidence keeps hitting the same